title: B7 family checkpoint regulators in immune regulation and disease.
abstract: Fine-tuning the immune response and maintaining tolerance to self-antigens involves a complex network of co-stimulatory and co-inhibitory molecules. The recent FDA approval of ipilimumab, a monoclonal antibody blocking cytotoxic T lymphocyte antigen (CTLA)-4, demonstrates the impact of checkpoint regulators in disease. This is reinforced by ongoing clinical trials targeting not only CTLA-4, but also the programmed death (PD)-1 and B7-H4 pathways in various disease states. Recently, two new B7 family inhibitory ligands, V-domain Ig suppressor of T cell activation (VISTA) and B7-H6 were identified. Here, we review recent understanding of B7 family members and their concerted regulation of the immune response to either self or foreign pathogens. We also discuss clinical developments in targeting these pathways in different disease settings, and introduce VISTA as a putative therapeutic target.
authors: Geisel School of Medicine at Dartmouth, Department of Microbiology and Immunology, Norris Cotton Cancer Centre, 1 Medical Center Drive, Lebanon, New Hampshire 03756, USA.
authors: Sabrina
authors: S
authors: Ceeraz
authors: Elizabeth C
authors: EC
authors: Nowak
authors: Randolph J
authors: RJ
authors: Noelle
mesh_terms: D000818:Animals; D060887:B7 Antigens / Q000276:immunology*; D060908:CTLA-4 Antigen / Q000276:immunology*; D006801:Humans; D007108:Immune Tolerance / Q000276:immunology*; D007109:Immunity / Q000276:immunology*; D061026:Programmed Cell Death 1 Receptor / Q000276:immunology*; D060907:V-Set Domain-Containing T-Cell Activation Inhibitor 1 / Q000276:immunology*
chemical_list: D060887:B7 Antigens; D060908:CTLA-4 Antigen; D061026:Programmed Cell Death 1 Receptor; D060907:V-Set Domain-Containing T-Cell Activation Inhibitor 1
keywords: B7 family; co-inhibitory molecules; co-stimulatory molecules
references: J Exp Med. 2009 Jul 6;206(7):1495-503
references: 19528259
references: Immunity. 1995 Jul;3(1):87-98
references: 7621080
references: J Immunol. 2011 Aug 15;187(4):1537-41
references: 21768399
references: Cancer Immunol Immunother. 2010 Aug;59(8):1163-71
references: 20333377
references: J Neurooncol. 2008 Sep;89(2):121-9
references: 18478183
references: Science. 2001 Jan 12;291(5502):319-22
references: 11209085
references: Blood. 2009 Feb 19;113(8):1759-67
references: 19109567
references: Immunity. 2000 Jul;13(1):95-105
references: 10933398
references: Crit Rev Immunol. 1998;18(5):389-418
references: 9784967
references: J Immunol. 2003 Oct 1;171(7):3348-52
references: 14500627
references: Immunity. 2003 Jun;18(6):863-73
references: 12818166
references: Immunity. 1999 Oct;11(4):423-32
references: 10549624
references: Clin Cancer Res. 2011 May 15;17(10):3100-11
references: 21378130
references: Br J Pharmacol. 2010 Oct;161(3):512-26
references: 20880392
references: J Urol. 2011 Sep;186(3):1093-9
references: 21784485
references: N Engl J Med. 2006 Sep 7;355(10):1018-28
references: 16908486
references: Clin Cancer Res. 2011 Jul 15;17(14):4622-8
references: 21467163
references: Cancer Sci. 2011 May;102(5):1019-24
references: 21251161
references: J Immunol. 2012 Oct 15;189(8):4165-74
references: 22972920
references: J Surg Oncol. 2010 Dec 1;102(7):748-52
references: 20872810
references: Science. 1994 Aug 26;265(5176):1225-7
references: 7520604
references: J Immunol. 2002 Jun 15;168(12):6294-7
references: 12055244
references: Proc Assoc Am Physicians. 1995 Apr;107(1):41-6
references: 8630743
references: J Clin Immunol. 2011 Aug;31(4):588-95
references: 21487894
references: Eur J Immunol. 2009 Jul;39(7):1754-64
references: 19544488
references: Clin Cancer Res. 2007 Mar 15;13(6):1810-5
references: 17363537
references: J Immunol. 1997 Jan 15;158(2):658-65
references: 8992981
references: J Autoimmun. 2003 Nov;21(3):255-60
references: 14599850
references: Int Immunol. 2009 Sep;21(9):1065-77
references: 19651643
references: Immunity. 2003 Jun;18(6):849-61
references: 12818165
references: J Immunol. 2012 Sep 1;189(5):2290-9
references: 22851709
references: N Engl J Med. 2010 Aug 19;363(8):711-23
references: 20525992
references: Blood. 2011 Dec 22;118(26):6772-82
references: 21931118
references: Annu Rev Immunol. 2008;26:677-704
references: 18173375
references: Nat Immunol. 2005 Nov;6(11):1133-41
references: 16200068
references: Nat Immunol. 2001 Mar;2(3):269-74
references: 11224528
references: J Immunol. 2010 Sep 15;185(6):3677-84
references: 20696859
references: J Immunol. 2005 Nov 1;175(9):5774-82
references: 16237069
references: J Immunol. 2004 Oct 15;173(8):4919-28
references: 15470033
references: J Exp Med. 2012 Feb 13;209(2):201-9
references: 22330682
references: J Immunol. 2003 Nov 1;171(9):4650-4
references: 14568939
references: N Engl J Med. 2012 Jun 28;366(26):2443-54
references: 22658127
references: J Clin Invest. 1995 Jun;95(6):2783-9
references: 7539461
references: Immunity. 1994 Aug;1(5):405-13
references: 7882171
references: Immunity. 2011 May 27;34(5):729-40
references: 21530327
references: Gynecol Oncol. 2012 Jan;124(1):105-11
references: 21982044
references: Nature. 2001 Jan 4;409(6816):97-101
references: 11343121
references: J Exp Med. 2003 Jul 7;198(1):71-8
references: 12847138
references: Autoimmun Rev. 2013 May;12(7):758-67
references: 23340277
references: Immunity. 1999 Aug;11(2):141-51
references: 10485649
references: Int J Gynecol Cancer. 2009 Dec;19(9):1481-6
references: 19955922
references: Science. 1995 Nov 10;270(5238):985-8
references: 7481803
references: Nat Immunol. 2003 Jul;4(7):670-9
references: 12796776
references: J Exp Med. 2011 Mar 14;208(3):577-92
references: 21383057
references: J Exp Med. 2011 Aug 1;208(8):1683-94
references: 21727190
references: Immunity. 1994 Sep;1(6):443-6
references: 7534615
references: J Neurooncol. 2013 Feb;111(3):257-64
references: 23232807
references: Immunity. 2011 Jun 24;34(6):932-46
references: 21636296
references: Cancer Res. 2009 Aug 1;69(15):6275-81
references: 19584290
references: Cell Transplant. 2012;21(1):99-111
references: 21929869
references: Transpl Immunol. 2009 Jul;21(3):143-9
references: 19361556
references: Neurology. 2008 Sep 16;71(12):917-24
references: 18794494
references: Semin Oncol. 2010 Oct;37(5):450-4
references: 21074059
references: Int J Cancer. 2012 May 15;130(10):2282-90
references: 21671471
references: Cancer Sci. 2010 Nov;101(11):2368-74
references: 20666777
references: Exp Cell Res. 2013 Jan 1;319(1):96-102
references: 22999863
references: Cancer Immunol Immunother. 2011 Jul;60(7):1047-55
references: 21519829
references: Immunity. 2007 Jul;27(1):111-22
references: 17629517
references: Int J Oncol. 2011 May;38(5):1219-26
references: 21344157
references: J Immunol. 2012 Jul 1;189(1):39-49
references: 22634623
references: Cancer Immunol Immunother. 2010 Nov;59(11):1707-14
references: 20725832
references: J Exp Med. 2003 Jul 7;198(1):63-9
references: 12847137
references: J Allergy Clin Immunol. 2008 Nov;122(5):890-2
references: 18805577
references: Nature. 1999 Dec 16;402(6763):827-32
references: 10617205
references: PLoS Med. 2009 Oct;6(10):e1000166
references: 19841745
references: Nature. 1999 Jan 21;397(6716):263-6
references: 9930702
references: J Neurooncol. 2010 May;97(3):409-18
references: 19890606
references: J Int Med Res. 2012;40(2):497-506
references: 22613410
references: Eur J Immunol. 2010 Aug;40(8):2267-76
references: 20544729
references: J Mol Neurosci. 2009 Jan;37(1):86-94
references: 18690554
references: Biochem Biophys Res Commun. 2009 Nov 13;389(2):349-53
references: 19723502
references: Clin Cancer Res. 2009 Mar 15;15(6):2174-80
references: 19276267
references: Cancer Res. 2011 Aug 15;71(16):5445-54
references: 21708958
references: Transplant Proc. 2010 Nov;42(9):3489-96
references: 21094802
references: Mol Cell Biol. 2005 Nov;25(21):9543-53
references: 16227604
references: Clin Cancer Res. 2008 May 15;14(10):3044-51
references: 18483370
references: Cancer Lett. 2008 Aug 8;266(2):227-37
references: 18417276
references: Proc Natl Acad Sci U S A. 2003 Sep 2;100(18):10388-92
references: 12920180
references: Transplantation. 2009 Feb 27;87(4):482-90
references: 19307783
references: World J Surg. 2011 Sep;35(9):2051-7
references: 21748517
references: Ann Surg. 2010 Dec;252(6):1044-51
references: 21107115
references: Proc Natl Acad Sci U S A. 2011 Oct 4;108(40):16723-8
references: 21933959
references: Lung Cancer. 2009 Nov;66(2):245-9
references: 19269710
references: J Immunol. 2012 Nov 15;189(10):5037-46
references: 23066150
references: J Exp Med. 2011 Apr 11;208(4):703-14
references: 21422170
references: Arthritis Rheum. 2008 Aug;58(8):2498-510
references: 18668554
references: J Biol Chem. 2010 Mar 5;285(10):7776-83
references: 20042595
references: Diabetes. 2011 Dec;60(12):3246-55
references: 21984581
references: Transplantation. 2013 Jan 15;95(1):94-9
references: 23192157
references: Cancer Lett. 2012 Apr 1;317(1):99-105
references: 22108530
references: J Immunol. 2000 Nov 1;165(9):5035-40
references: 11046032
references: PLoS One. 2012;7(1):e28232
references: 22238573
references: Science. 1996 Jul 5;273(5271):104-6
references: 8658175
references: Immunology. 2009 Nov;128(3):360-8
references: 20067536
references: J Clin Invest. 1995 Aug;96(2):987-93
references: 7543497
references: Proc Natl Acad Sci U S A. 2008 Sep 30;105(39):14987-92
references: 18818309
references: Lancet. 2011 Jul 30;378(9789):412-9
references: 21719096
references: J Biol Chem. 2005 Nov 25;280(47):39553-61
references: 16169851
references: Science. 2011 Apr 29;332(6029):600-3
references: 21474713
references: Immunol Rev. 2011 Nov;244(1):169-87
references: 22017438
references: Proc Natl Acad Sci U S A. 2008 Jul 29;105(30):10495-500
references: 18650384
references: J Immunother. 2012 May;35(4):354-8
references: 22495393
references: Immunology. 2008 Apr;123(4):538-46
references: 18194267
references: J Clin Oncol. 2010 Jul 1;28(19):3167-75
references: 20516446